[Behavior of electromyographic findings in subjects with progressive muscular dystrophy during remetabolizing therapy].
D000255:Adenosine Triphosphate / Q000627:therapeutic use; D045930:Anabolic Agents / Q000627:therapeutic use; D004576:Electromyography; D006801:Humans; D008274:Magnesium / Q000627:therapeutic use; D008715:Methionine / Q000627:therapeutic use; D009136:Muscular Dystrophies; D011188:Potassium / Q000627:therapeutic use; D014500:Uracil Nucleotides / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use
D045930:Anabolic Agents; D014500:Uracil Nucleotides; D014815:Vitamins; D000255:Adenosine Triphosphate; D008715:Methionine; D008274:Magnesium; D011188:Potassium
Comportamento dei reperti elettromiografici in soggetti con distrodia muscolare progressiva durante terapia rimetabolizzante.